On August 27, 2026, Clinuvel Pharmaceuticals Ltd (ticker: CUVL) released its fiscal year results and announced a strategic upgrade of its U.S. listing to Nasdaq...
Market Samachar is a news aggregator. This article was originally published by gurufocus.com. Tap the button above to read the full story on their site.